EZH2 and breast cancer: RELA has shown an increased methylation level that is significant in the progression of breast cancer [47], HMOX2 has shown an increased hypomethylation in endometriosis [48], while EZH2 mediates histone modification H3K27m3 and causes several cancers [49].